Clinical trial
Impact of Early High-dose Atorvastatin Versus Rosuvastatin on Contrast Induced Acute Kidney Injury in Unselected Patients With Non- ST Elevation Acute Coronary Syndromes Scheduled for Early Invasive Strategy.
NCT01870804 is registered in ClinicalTrials.gov with Centro Cardiopatici Toscani as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Early High-dose Atorvastatin Versus Rosuvastatin on Contrast Induced Acute Kidney Injury in Unselected Patients With Non- ST Elevation Acute Coronary Syndromes Scheduled for Early Invasive Strategy.
- Lead sponsor
- Centro Cardiopatici Toscani
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 31, 2013
- Completion date
- September 30, 2016
- Enrollment
- 760 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.